Clinical Trials Directory

Trials / Completed

CompletedNCT00566709

Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients

Phase II Study of Usefulness of Near Infrared Spectroscopy to Optimize Red Blood Cells Transfusion in Neuro Critical Ill Patients With Severe Traumatic Brain Injury, Subarachnoid Hemorrhage or Intracerebral Hemorrhage.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Hospitales Universitarios Virgen del Rocío · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Neurocritical ill patients are frequently transfused. Red blood cell transfusion (RBCT) in these patients has been associated with deleterious effects, including higher rates of nosocomial infections, multi-organ failure, and mortality. Therefore, it seems crucial to avoid any unnecessary RBCT. Most critically ill patients tolerate hemoglobin levels near 7 g/dL without an increase in morbidity or mortality rates. In this regard, a recent sub-analysis of TRICC trial has showed that TBI patients may tolerate hemoglobin levels as low as 7 g/dL, but other studies including neurocritical patients suggested that severe anemia may worsen clinical outcome. Therefore, optimal hemoglobin levels in neurocritical care patients remain largely unknown. Some textbooks and guidelines recommend to transfuse these patients to reach hemoglobin levels near to 10 g/dL, despite the lack of a solid scientific background supporting this target. Even though it has not been demonstrated, hemoglobin-based RBCT prescription could result in over- or under-transfusion in neurocritical patients. Alternatively, it has been suggested that more physiological transfusion triggers, using direct signals coming from the brain, will progressively replace arbitrary hemoglobin-based transfusion triggers in the neurocritical patients \[65\]. At the neurocritical units, patients are often monitored by using non-invasive methods, such as near infrared spectroscopy which indirectly measures regional cerebral oxygen saturation (rSO2). Changes in rSO2 values have been shown to directly correlate with changes in erythrocyte mass, thus increasing with RBCT and decreasing with blood losses. Moreover, rSO2 values also show a good correlation with clinical outcome and other variables which are often monitored in TBI patients. The purpose of this study is to ascertain as to whether rSO2 levels are more efficacious than conventional hemoglobin levels in guiding RBCT in patients admitted to a neurocritical care unit.

Conditions

Interventions

TypeNameDescription
PROCEDURERed blood cells transfusionPatients will be transfused (one to one red blood cells unit transfusion)

Timeline

Start date
2009-06-01
Primary completion
2009-11-01
Completion
2009-12-01
First posted
2007-12-03
Last updated
2016-04-19
Results posted
2016-03-11

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00566709. Inclusion in this directory is not an endorsement.